Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

Valeant Pharmaceuticals (VRX) Stock: No Bottom in Sight

NEW YORK (TheStreet) -- The media coverage around Valeant Pharmaceuticals (VRX - Get Report) has become a Clash of Titans-type spectacle between visible hedge fund managers with a high tolerance for risk and a Web publisher/researcher who compares it to Enron (a firm I interviewed with years ago -- a story best told over drinks).

Despite a huge percentage decline in the past three months, VRX has not shown any signs that it may have reached a low or bottom. In this first chart of VRX, we can see the three-month slide. VRX broke below the 50-day simple moving average in August and then...


More